Home » Topics » Disease categories and therapies » Immune

Immune
RSS

New immunosuppressant and antitumor compound isolated at Takeda

Nov. 29, 2002

FluINsure vaccine challenge trial commences

Nov. 29, 2002

New vaccines reported effective against HPV and HSV infections

Nov. 29, 2002

Phosphodiesterase inhibitors discovered at Ortho-McNeil

Nov. 28, 2002

Chemokine CXCR3 antagonists designed by Millennium and Kyowa Hakko

Nov. 27, 2002

Canadian approval for Thymoglobulin in renal transplant patients

Nov. 27, 2002

Japan Energy and Sumitomo describe new immunomodulators for cancer and other disorders

Nov. 26, 2002

Cannabinoid CB2 receptor modulators under study at Shionogi

Nov. 22, 2002

Cytos and Medarex collaborate for new drug targets in immunological diseases

Nov. 18, 2002

Myfortic receives first major approval in Switzerland

Nov. 8, 2002

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...